학술논문
156P Matching-adjusted indirect comparison (MAIC) of palbociclib versus ribociclib and abemaciclib in hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer (HR+/HER2 ABC)
Document Type
Abstract
Author
Source
In Annals of Oncology May 2020 31 Supplement 2:S72-S72
Subject
Language
ISSN
0923-7534